A Phase 1 Study of Intravenous EGFR-ErbituxEDVsMIT in Children with Solid or CNS Tumours Expressing Epidermal Growth Factor Receptor-Reference-Cited by-同舟云学术

A Phase 1 Study of Intravenous EGFR-ErbituxEDVsMIT in Children with Solid or CNS Tumours Expressing Epidermal Growth Factor Receptor

Published:2024-03-28 Issue:3 Volume:19 Page:333-342
ISSN:1776-2596
Container-title:Targeted Oncology
language:en
Short-container-title:Targ Oncol

Author:

Evans Louise,Walker Rick,MacDiarmid Jennifer,Brahmbhatt Himanshu,Anazodo Antoinette,McCowage Geoffrey,Gifford Andrew J.,Kavallaris Maria,Trahair Toby,Ziegler David S.^ORCID

Funder

Sydney Children's Hospital Foundation

Cancer Institute NSW

National Health and Medical Research Council

University of New South Wales

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11523-024-01051-2.pdf

Reference19 articles.

1. Solomon BJ, Desai J, Rosenthal M, McArthur GA, Pattison ST, Pattison SL, et al. A first-time-in-human phase I clinical trial of bispecific antibody-targeted, paclitaxel-packaged bacterial minicells. PLoS ONE. 2015;10: e0144559. https://doi.org/10.1371/journal.pone.0144559.

2. MacDiarmid JA, Madrid-Weiss J, Amaro-Mugridge NB, Phillips L, Brahmbhatt H. Bacterially-derived nanocells for tumor-targeted delivery of chemotherapeutics and cell cycle inhibitors. Cell Cycle. 2007;6:2099–105. https://doi.org/10.4161/cc.6.17.4648.

3. Ma L, King GF, Rothfield L. Positioning of the MinE binding site on the MinD surface suggests a plausible mechanism for activation of the Escherichia coli MinD ATPase during division site selection. Mol Microbiol. 2004;54:99–108. https://doi.org/10.1111/j.1365-2958.2004.04265.x.

4. MacDiarmid JA, Mugridge NB, Weiss JC, Phillips L, Burn AL, Paulin RP, et al. Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics. Cancer Cell. 2007;11:431–45. https://doi.org/10.1016/j.ccr.2007.03.012.

5. MacDiarmid JA, Langova V, Bailey D, Pattison ST, Pattison SL, Christensen N, et al. targeted doxorubicin delivery to brain tumors via minicells: proof of principle using dogs with spontaneously occurring tumors as a model. PLoS ONE. 2016;11: e0151832. https://doi.org/10.1371/journal.pone.0151832.